← Back to Search

Behavioral Intervention

Augmented Reality for Loneliness

N/A

Recruiting

Led By Nilanjan Sarkar

Research Sponsored by Vanderbilt University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 60 and older

Be older than 18 years old

Must not have

Unable to understand or speak English

Physical impairment that impedes participation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 4

Awards & highlights

No Placebo-Only Group

Summary

This trial wants to see if using a special type of glasses that show computer-generated images in older adults living in long term care homes is a good idea. They want to find out if people like using

Who is the study for?

This trial is for older adults aged 60 or above who have been living in long-term care facilities for more than three months. Participants must be able to give consent and understand English. Those with physical impairments that prevent participation or those who are terminally ill cannot join.

What is being tested?

The study is examining the effectiveness of using head-mounted display augmented reality (HMD AR) versus traditional two-dimensional audio-video (2-D AV) communication to reduce loneliness in older adults. It involves 8 sessions over 4 weeks, assessing feasibility, acceptability, and satisfaction.

What are the potential side effects?

While not explicitly stated, potential side effects may include discomfort from wearing HMD AR devices, eye strain, dizziness or motion sickness from the virtual environment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot understand or speak English.

Select...

I have a physical condition that prevents me from joining.

Select...

I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of Intervention Measure (AIM)

Feasibility of Intervention Measure (FIM) questionnaire

Networked Minds Measure (NMM) of Social Presence

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: HMD ARExperimental Treatment1 Intervention

Pairs of older adults with their designated family members who geographically apart will perform collaborative activities using HMD AR in 8 sessions over 4 weeks.

Group II: 2-D Audio-VisualActive Control1 Intervention

Pairs of older adults with their designated family members who geographically apart will perform collaborative activities using 2-D Audio-Visual in 8 sessions over 4 weeks.

0 / 4Eligibility criteria met